Pfizer sets up global drug development centre in Chennai
The facility is among 12 centres established worldwide, and the first in Asia
The facility is among 12 centres established worldwide, and the first in Asia
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
The goal for the project is the identification and optimization of anti-viral compounds.
TB Alliance will continue to lead clinical development, while Lupin will leverage its global manufacturing, regulatory, and supply chain expertise to ensure the drug reaches patients worldwide
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
Experts caution that realizing AI’s potential requires careful management and risk mitigation
Preclinical studies show that 4P004 modulates multiple biological markers across the joint, potentially slowing structural damage while improving function
The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof
Subscribe To Our Newsletter & Stay Updated